AzTrials
AzTrials

Body Dysmorphic DisorderNCT05402475

Online Cognitive Behavioural Therapy Intervention for Body Dysmorphic Disorder

A study testing CBT + Mindfulness in people with Body Dysmorphic Disorder and Body Image Disturbance, run by York University at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Body Dysmorphic Disorder (BDD) affects 2.3% of the population and is characterized by excessive concerns with imagined or minor defects in physical appearance. Retrospective outcome studies suggest patients affected by BDD don't typically benefit from surgical treatments while cognitive behaviour therapy (CBT) appears… Read more about this study

Who is it for?
Ages 18 to 55 years
What is being tested?
CBT + Mindfulness
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteCanada
Study dates
1 Sep 2022to 1 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Inclusion Criteria: On the Body Dysmorphic Disorder Questionnaire, responses indicating current BDD status; -

Exclusion Criteria: Individuals who are currently receiving weekly structured psychotherapy or who meet DSM-V criteria for severe alcohol/substance use disorder in the past 3 months or demonstrated clinically significant suicidal ideation defined as imminent intent, or attempted suicide in the past 6 months. Individuals of co-morbid diagnoses of borderline personality, schizophrenia, bipolar disorder and/or obsessive compulsive disorder are excluded.

-

Trial locations and contacts

1 site in 1 country.

Paul Ritvo, PhD contact

4165808021

pritvo@yorku.ca

Camrie Kerry, BA contact

Camrie@yorku.ca

Canada1 site, 1 recruiting
  • York University

    Toronto, Ontario, M4E 3C1

    York University, 4165808021

    Paul G Ritvo, PhD, 4165808021 ext. Ritvo, pritvo@yorku.ca

    Recruiting

Other trials in Canada

About this study

Official title: Online Cognitive Behavioural Therapy (CBT) Intervention for Body Dysmorphic Disorder: Comparison of CBT - Mindfulness to CBT Alone

Body Dysmorphic Disorder (BDD) affects 2.3% of the population and is characterized by excessive concerns with imagined or minor defects in physical appearance. Retrospective outcome studies suggest patients affected by BDD don't typically benefit from surgical treatments while cognitive behaviour therapy (CBT) appears to provide symptom - reducing and distress - reducing benefits. Two different 8-week online CBT approaches to assisting individuals with this disorder are compared: one approach will integrate mindfulness meditation methods (in combination with CBT) and one approach will employ CBT methods without reference to mindfulness meditation.

Read the detailed description

Body Dysmorphic Disorder (BDD) affects 2.3% of the population and is characterized by excessive concerns with imagined or minor defects in physical appearance. Retrospective outcome studies suggest patients affected by BDD typically do not benefit from surgical treatments while cognitive behaviour therapy (CBT) appears to provide symptom - reducing and distress - reducing benefits. In this study two different 8-week online CBT approaches to assist individuals with this disorder are compared: one approach will integrate mindfulness meditation methods (in combination with CBT) and one approach will employ CBT methods without reference to mindfulness meditation.

The purpose of this comparison is to ascertain whether the inclusions of the two additional intervention modalities, demonstrated effective in other studies, adds to positive outcome effects in this disorder. A primary hypothesis is that the 8 week post-intervention outcomes associated with the CBT-mindfulness approach will show significantly more benefit than the comparison group.

Being tested
CBT + Mindfulness
Keywords
internet-based intervention with health coaching
Medical subject headings
Body Dysmorphic Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CBT + MindfulnessBehavioural

    Eight weeks of online CBT intervention combined with mindfulness

Study groups in NCT05402475
Study groupRoleWhat they receive
ExperimentalExperimentalOnline cognitive behavioural therapy with the added components of mindfulness meditation
Receives: Behavioral: CBT + Mindfulness
Active comparatorActive comparatorOnline cognitive behavioural therapy alone
Receives: Behavioral: CBT + Mindfulness

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Body Dysmorphic Disorder Symptom Scale

    A 55-item scale which asks for presence/absence of symptoms and the degree of severity

    Measured: Baseline, Post-Intervention at 8 weeks following Baseline

Secondary outcomes (1)
  1. Patient Health Questionnaire - 9

    A 9-item self report scale that asks for symptoms of depression and anxiety

    Measured: Baseline, Post-Intervention at 8 weeks following Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jun 2022
  2. Study start1 Sep 2022
  3. Primary completion1 Oct 2023 (estimated)
  4. Study completion1 Nov 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a parallel group randomized clinical trial with two active comparison conditions
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05402475
Sponsor's protocol ID
DHRF - 02
Status last verified
Jul 2023
First submitted
23 May 2022
Last updated
7 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Publication of results

Publications

  • Kuck N, Cafitz L, Burkner PC, Hoppen L, Wilhelm S, Buhlmann U. Body dysmorphic disorder and self-esteem: a meta-analysis. BMC Psychiatry. 2021 Jun 15;21(1):310. doi: 10.1186/s12888-021-03185-3.

    PubMed 34130638
  • Kerry C, Mann P, Babaei N, Katz J, Pirbaglou M, Ritvo P. Web-Based Therapist-Guided Mindfulness-Based Cognitive Behavioral Therapy for Body Dysmorphic Disorder: Pilot Randomized Controlled Trial. JMIR Ment Health. 2024 Jun 12;11:e55283. doi: 10.2196/55283.

    PubMed 38865704

Questions about this trial

What is this clinical trial studying?

A study testing CBT + Mindfulness in people with Body Dysmorphic Disorder and Body Image Disturbance, run by York University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Paul Ritvo, PhD (4165808021, pritvo@yorku.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Body Dysmorphic Disorder Symptom Scale (time frame: Baseline, Post-Intervention at 8 weeks following Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05402475, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in